Shuji Momose

6PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Oncology and carcinogenesis not elsewhere classifiedMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 18, 2025
Significance and Utility of Immunohistochemical MTAP Expression to Predict CDKN2A Genomic Status in Diffuse Large B-Cell Lymphoma.

Kozue Ito, Hiroki Imada, Marino Nagata

|Jun 03, 2025
Genetic Profiling Reveals the Distinctions Among MTX-Associated DLBCL, EBV-Positive Mucocutaneous Ulcer, and EBV + DLBCL.

Takumi Takahashi, Keisuke Sawada, Takahisa Yamashita

|Aug 08, 2023
Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study.

Tomohiro Urata, Yusuke Naoi, Aixiang Jiang

|May 17, 2023
UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.

Ola Rizq, Naoya Mimura, Motohiko Oshima

|Dec 19, 2019
Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomas.

Yuka Tanaka, Shuji Momose, Takayuki Tabayashi

Pageof 1

Frequent Collaborators

2 joint publications

Kiyoshi Yamaguchi

2 joint publications

Emiko Sakaida

2 joint publications

Yu-Tzu Tai

2 joint publications

Kenneth C Anderson